Australian Foundation Investment Company Limited logo

2021 Annual General Meeting Presentation

AGM4 October 2021AFIFinancials

5 October 2021



The Manager

ASX Market Announcements

Australian Securities Exchange

Exchange Centre

Level 4

20 Bridge Street

Sydney NSW 2000



Electronic Lodgement



Australian Foundation Investment Company Limited

2021 Annual General Meeting Presentation



Dear Sir / Madam


The following presentation will be delivered to shareholders at the Company’s Annual

General Meeting to be held today.


Yours faithfully



Matthew Rowe

Company Secretary



Authorised for release by the Company Secretary

Annual General Meeting
2021

Annual General Meeting 2021
Board Members

John Paterson

Chairman and Independent

Non-Executive Director

Craig Drummond

Independent Non-Executive

Director

Mark Freeman

Managing Director

Julie Fahey

Independent Non-Executive

Director

David A Peever

Independent Non-Executive

Director

Rebecca Dee-Bradbury

Independent Non-Executive

Director

Graeme R Liebelt

Independent Non-Executive

Director

Catherine M Walter AM

Independent Non-Executive

Director

Peter J Williams

Independent Non-Executive

Director

2

Annual General Meeting
2021

Presentation

Annual General Meeting 2021
Australian Foundation Investment Company Limited and its subsidiary AICS (AFSL 303209), their

related entities and each of their respective directors, officers and agents (together the Disclosers) have

prepared the information contained in these materials in good faith. However, no warranty (express or

implied) is made as to the accuracy, completeness or reliability of any statements, estimates or opinions

or other information contained in these materials (any of which may change without notice) and to the

maximum extent permitted by law, the Disclosers disclaim all liability and responsibility (including,

without limitation, any liability arising from fault or negligence on the part of any or all of the Disclosers)

for any direct or indirect loss or damage which may be suffered by any recipient through relying on

anything contained in or omitted from these materials.

This information has been prepared and provided by AICS. To the extent that it includes any financial

product advice, the advice is of a general nature only and does not take into account any individual’s

objectives, financial situation or particular needs. Before making an investment decision an individual

should assess whether it meets their own needs and consult a financial advisor.

Disclaimer

4

Annual General Meeting 2021
Our Company

Invests in Australian and New Zealand companies –looking for quality for the long term.

Largest listed investment company on the ASX at $9.4bn at 31 August 2021 (also listed on NZX), 160k shareholders, full

transparency from being listed,independent Board of Directors providing strong governance.

Shareholders own the ‘management rights’ to the portfolio – no external funds management business deriving

an income from the portfolio.

Management expense ratio of 0.14% with no performance fees.

Long term investor with low turnover –tax has less of a negative impact on shareholder returns compared with high

turnover funds.

Long history of growing/stable fully franked dividends.

Team manages three other funds –Djerriwarrh, Mirrabookaand AMCIL which adds significantly to the effectiveness

of the investment process and idea generation.

3

5

Annual General Meeting 2021
Investment Team

David Grace

Portfolio Manager

Kieran Kennedy

Portfolio Manager

Brett McNeill

Portfolio Manager

Rosie Malcolm

Portfolio Manager

Andrew Sutherland

Portfolio Manager

Nga Lucas

Investment Analyst

Olga Kosciuczyk

Investment Analyst

Stuart Low

Investment Analyst

Jeremy Moore

Dealer

Gilbert Battistella

Graduate Investment

Analyst

Nicky Sun

Graduate Investment

Analyst

Jaye Guy

Investment Analyst

6

Annual General Meeting 2021
Long term value in the context of recent market moves

Source: FactSetSource: FactSet

Price to Book -

S&P/ASX 200 Index

Price to Sales -

S&P/ASX 200 Index

7

Annual General Meeting 2021
Result Summary

Annual General Meeting 2021
Result Summary

*Assumes an investor can take full advantage of the franking credits

9

Annual General Meeting 2021
AFIC’s share price relativeto the NTA- 31 August 2021

10

Annual General Meeting 2021
Investment Objectives and

Approach

Annual General Meeting 2021
Investment Objectives

The Company aims to provide

shareholders with attractive investment

returns through access to a growing

stream of fully franked dividends

and growth in capital invested.

The Company’s primary investment goals are:

• to pay dividends which, over time, grow

faster than the rate of inflation; and

• to provide attractive total returns over

the medium to long term.

12

Annual General Meeting 2021
Our investment process – how we assess quality

Uniqueness of Assets

Long-term Sustainability

Independence

People

EarningsConsistency

Financial Strength

Competitivelandscape, leadership position, can the assets be replicated

Barriersto entry, sustainability of competitive advantage, track record of new entrants,

threat of substitution

Pricing power, bargaining power of suppliers, government interference, exposure to

commodity cycles

Owner/driver model, insider buying/selling, track record, remuneration incentives,

corporate governance

Volatility and quality of earnings, cash flow analysis

Balancesheet gearing, structure of the debt book, dividend policy, ability to invest for

future growth

13

Annual General Meeting 2021
Long term investor in companies, not traders of share prices

Identify quality companies with sound growth prospects that we can buy at a reasonable price

This supports our belief in the power of compounding returns from great businesses

Our research process is built on observing the key characteristics of a company that our experience

indicates will produce strong investment returns

Our investment process – focus on long term quality

14

Annual General Meeting 2021
Long-term approach

AFIC invests in high quality companies and benefits from compounding returns.

RMD Total Shareholder Return (%)

First added to the portfolio: August 2013

First added to the portfolio: November 2010

ARB Total Shareholder Return (%)

15

Annual General Meeting 2021
ESG is integrated into our investment framework

oAssessment of ESG risk factors is an important part of our investment process as the

sustainability of a business is a key input in our assessment of a company.

oAs a long-term investor, we seek to invest in companies that have strong governance and risk

management processes, which includes consideration of environmental and social risks.

oWe regularly review companies to ensure ongoing alignment with our investment framework.

oWe conduct our own evaluation of the merits of any shareholder resolution and take input from

proxy advisors.

oWe vote on all company resolutions as part of ourregular engagement with companies.

oWe actively engage with companies when we have concerns those resolutions are not aligned

with shareholders’ interests.

Engagement with companies

Approach to Environmental, Social and Governance (ESG) factors

Voting on resolutions is one of the key functions that a shareholder has in ensuring better long-

term returns and management of investment risk:

16

Annual General Meeting 2021
Markets and The Portfolio

Annual General Meeting 2021
Market and key sector performance*- Year to 31 August 2021

* includes dividends but not franking

18

Annual General Meeting 2021
Source: Mercer Investment Performance Survey of Wholesale-Equity – Australia. Note AFIC’s return is after tax paid and

costs. The universe for Wholesale-Equity – Australia returns are before tax and after fees

Over the 4-year period to 31 August 2021 AFIC has a higher

portfolio return with less volatility than the S&P/ASX 200 Index

(both exclude franking)

Note AFIC share price returns have a significantly lower volatility (beta

and standard deviation) than the Index.

Portfolio performance, including franking*

- per annum returns to 31 August 2021

Portfolio performance metrics

19

Annual General Meeting 2021
AFIC’s Performance relative to the Index (FY20-FY21)

4000

4500

5000

5500

6000

6500

7000

7500

8000

S&P/ASX200 Index

AFIC's Outperformance1H20

+1.69%

AFIC's Outperformance2H20

+1.87%

AFIC's Outperformance1H21

+1.43%

AFIC's Outperformance2H21

+1.02%

1H202H20

1H21

2H21

Source: FactSet

20

Annual General Meeting 2021
Portfolio Update - Recent Transactions

New

Purchases

SalesTrimmed

Additions to

existing holdings

21

Annual General Meeting 2021
Core holdings with significant

long-term opportunity

Annual General Meeting 2021
Xero

•Cloud accounting penetration continues to grow

globallydriven by Government digitization initiatives

•Strong market positions in Australia, New

Zealand and the UK with growing presence in

rest of world

•Strong subscriber and ARPU growth supported

by high R&D investment and acquisitions

•Long runway of growth with large growing global

addressable markets

0

100

200

300

400

500

600

700

800

FY17FY18FY19FY20FY21

$NZm

AustraliaNZUKNorth AmericaROW

Xero Revenue: FY17-FY21

$407m

$700m

$849m

Source: Xero

$553m

$295m

•Software-as-a-service (SAAS) revenue model and

leading SAAS economics delivers superior returns

23

Annual General Meeting 2021
Carsales

•Dominant market position in used car classifieds in Australia with 4.4m average monthly unique

audience (4.5x lead over nearest competitor).

•Growing contribution from international businesses, now represents ~35% of group profit.

•“CarsalesSelect” to facilitate a fully digital car buying/selling experience for consumers and dealers.

US (TRADER INTERACTIVE)

Recreational market share

SOUTH KOREA (ENCAR)

Full year market share v competition

Source: Carsales

Full year market share v competition

BRAZIL (WEBMOTORS)

24

Annual General Meeting 2021
For every 100 U.S. adults...

4 KNOW THEY HAVE SLEEP APNEA

22 DON’T KNOW THEY HAVE IT

ResMed

•Market leader in the treatment of Obstructive Sleep

Apnea(OSA).

•Condition remains largely undiagnosed. Provenlink

between the incidence of obesity and requirement for

OSA treatment.

•Significantinvestment in Research and

Developmentbeing 7% of sales.

•Resmedinvesting in raising consumer awareness

around OSA.

•High returnon capitalwith a strong balance sheet.

Source: © 2019 ResMed

Sleep apneais more than 80% undiagnosed...

... and is highly prevalent in other chronic conditions

25

Annual General Meeting 2021
•Fibre cement market share has doubled since

2005, all other materials have declined.

•Marketleader in fibre cement siding with

more than 90% market share

•Favourably exposed to the shift to lightweight

materials being less carbon intensive

James Hardie

Vinyl

Stucco

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

2005200620072008200920102011201220132014201520162017201820192020

Brick

Fibre cement

Wood

Wall Share Chart

Source: Macquarie, US Census Bureau’s Characteristics of Housing survey

Other

•High return oncapital and strong balance

sheet.

26

Annual General Meeting 2021
Top 30 holdings – 31 August 2021

RankCompany% ofPortfolio

1

Commonwealth Bank of Australia8.4%

2

CSL 7.3%

3

BHP Group 6.5%

4

Wesfarmers 4.7%

5

Westpac Banking Corporation4.3%

6

Macquarie Group 3.9%

7

Transurban Group 3.7%

8

National Australia Bank 3.3%

9

Mainfreight 3.1%

10

Woolworths Group 2.9%

Total Portfolio 64 Holdings

27

Annual General Meeting 2021
Top 30 holdings – 31 August 2021 continued

RankCompany% ofPortfolio

11

James Hardie Industries*2.7%

12

Australia and New Zealand Banking Group2.5%

13

Rio Tinto2.2%

14

Telstra Corporation*2.2%

15

Sydney Airport2.2%

16

Amcor2.2%

17

ARB Corporation1.9%

18

ResMed1.8%

19

Sonic Healthcare1.7%

20

Goodman Group1.6%

Total Portfolio 64 Holdings

* Options were outstanding against part of the holding.

28

Annual General Meeting 2021
Top 30 holdings – 31 August 2021 continued

RankCompany% ofPortfolio

21

Carsales.com1.6%

22

Reece1.6%

23

Coles Group1.6%

24

Ramsay Health Care1.4%

25

Xero1.3%

26

ASX1.3%

27

Fisher & Paykel Healthcare Corporation1.3%

28

Seek1.3%

29

IRESS1.2%

30

Brambles1.2%

Total Portfolio 64Holdings

29

Annual General Meeting 2021
Closing Comments

Annual General Meeting 2021
Outlook

We are mindful of:

•China growth slowing.

•Inflationary environment and potential end of rate easing cycle.

•Company dividends recovering.

Outlook for earnings growth remains solid, companies with international earnings

relatively better positioned to deliver.

Holding a diversified portfolio of quality companies remains appropriate.

31

Annual General Meeting 2021
International Portfolio

Invested a small amount ($47m/50bps) in International companies in May 2021.

Portfolio holdings in 39 companies.

Performance so far has been encouraging.

Applying the AFIC way of investing to International companies.

Looking to build a consistent track record.

32

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • AFT — AFT Pharmaceuticals Limited: ASM Presentation and Chair’s address
    2021-08-05

    Page 2 Importantnotice This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”), to provide a general overview of the performance of AFT for the financial year ended 31 March 2021. It is not prepared for any other purpose and must not be provided to any person…”